Frederik Prip

897 total citations
8 papers, 257 citations indexed

About

Frederik Prip is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Frederik Prip has authored 8 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Frederik Prip's work include Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Frederik Prip is often cited by papers focused on Bladder and Urothelial Cancer Treatments (7 papers), Urinary and Genital Oncology Studies (5 papers) and Cancer Immunotherapy and Biomarkers (3 papers). Frederik Prip collaborates with scholars based in Denmark, United States and Finland. Frederik Prip's co-authors include Jørgen Bjerggaard Jensen, Lars Dyrskjøt, Philippe Lamy, Sia V. Lindskrog, Iver Nordentoft, Torben Steiniche, Emil Christensen, Karin Birkenkamp‐Demtröder, Ann Taber and Michael Knudsen and has published in prestigious journals such as Nature Communications, Clinical Cancer Research and European Urology.

In The Last Decade

Frederik Prip

8 papers receiving 256 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederik Prip Denmark 7 196 113 69 55 45 8 257
Sia V. Lindskrog Denmark 8 331 1.7× 164 1.5× 118 1.7× 89 1.6× 97 2.2× 16 419
Ann Taber Denmark 3 121 0.6× 63 0.6× 44 0.6× 38 0.7× 21 0.5× 5 158
Nuno Vau Portugal 7 163 0.8× 93 0.8× 79 1.1× 128 2.3× 34 0.8× 13 267
Maciej Oszczudłowski Poland 5 156 0.8× 131 1.2× 74 1.1× 58 1.1× 84 1.9× 14 291
Scott J. Dawsey United States 5 100 0.5× 103 0.9× 99 1.4× 115 2.1× 49 1.1× 15 268
David Morris United States 8 65 0.3× 64 0.6× 102 1.5× 68 1.2× 39 0.9× 25 224
Daniel Oyón United States 4 130 0.7× 97 0.9× 30 0.4× 42 0.8× 29 0.6× 12 178
Juan Francisco Rodríguez-Moreno Spain 9 59 0.3× 74 0.7× 71 1.0× 86 1.6× 50 1.1× 37 192
Andrea Ochoa United States 5 379 1.9× 232 2.1× 132 1.9× 115 2.1× 81 1.8× 10 478
Yucai Wu China 9 74 0.4× 165 1.5× 83 1.2× 41 0.7× 133 3.0× 24 265

Countries citing papers authored by Frederik Prip

Since Specialization
Citations

This map shows the geographic impact of Frederik Prip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederik Prip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederik Prip more than expected).

Fields of papers citing papers by Frederik Prip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederik Prip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederik Prip. The network helps show where Frederik Prip may publish in the future.

Co-authorship network of co-authors of Frederik Prip

This figure shows the co-authorship network connecting the top 25 collaborators of Frederik Prip. A scholar is included among the top collaborators of Frederik Prip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederik Prip. Frederik Prip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Strandgaard, Trine, Iver Nordentoft, Karin Birkenkamp‐Demtröder, et al.. (2023). Field Cancerization Is Associated with Tumor Development, T-cell Exhaustion, and Clinical Outcomes in Bladder Cancer. European Urology. 85(1). 82–92. 21 indexed citations
2.
Lindskrog, Sia V., Iver Nordentoft, Philippe Lamy, et al.. (2023). Single-nucleus and Spatially Resolved Intratumor Subtype Heterogeneity in Bladder Cancer. European Urology Open Science. 51. 78–88. 12 indexed citations
3.
Strandgaard, Trine, Sia V. Lindskrog, Iver Nordentoft, et al.. (2022). Elevated T-cell Exhaustion and Urinary Tumor DNA Levels Are Associated with Bacillus Calmette-Guérin Failure in Patients with Non–muscle-invasive Bladder Cancer. European Urology. 82(6). 646–656. 39 indexed citations
4.
Taber, Ann, Frederik Prip, Philippe Lamy, et al.. (2022). Immune Contexture and Differentiation Features Predict Outcome in Bladder Cancer. European Urology Oncology. 5(2). 203–213. 9 indexed citations
5.
Taber, Ann, Frederik Prip, Jerry Xiao, et al.. (2021). STAG2 as a prognostic biomarker in low-grade non-muscle invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 39(7). 438.e1–438.e9. 12 indexed citations
6.
Botha, Jaco, et al.. (2021). Zoom in on Antibody Aggregates: A Potential Pitfall in the Search of Rare EV Populations. Biomedicines. 9(2). 206–206. 5 indexed citations
7.
Taber, Ann, Emil Christensen, Philippe Lamy, et al.. (2020). Molecular correlates of cisplatin-based chemotherapy response in muscle invasive bladder cancer by integrated multi-omics analysis. Nature Communications. 11(1). 4858–4858. 135 indexed citations
8.
Prip, Frederik, Brent T. Harris, David A. Solomon, et al.. (2018). STAG2 Is a Biomarker for Prediction of Recurrence and Progression in Papillary Non–Muscle-Invasive Bladder Cancer. Clinical Cancer Research. 24(17). 4145–4153. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026